Department of Biochemistry and Biotechnology, University of Thessaly, Ploutonos 26 & Eolou, 41221, Larissa, Greece.
Biotechnol Lett. 2012 Aug;34(8):1393-403. doi: 10.1007/s10529-012-0919-2. Epub 2012 Apr 6.
Non-ribosomal peptide synthetases (NRPS) and type-I polyketide synthases (PKS-I) are multimodular enzymes involved in biosynthesis of oligopeptide and polyketide secondary metabolites produced by microorganisms such as bacteria and fungi. New findings regarding the mechanisms underlying NRPS and PKS-I evolution illustrate how microorganisms expand their metabolic potential. During the last decade rapid development of bioinformatics tools as well as improved sequencing and annotation of microbial genomes led to discovery of novel bioactive compounds synthesized by NRPS and PKS-I through genome-mining. Taking advantage of these technological developments metagenomics is a fast growing research field which directly studies microbial genomes or specific gene groups and their products. Discovery of novel bioactive compounds synthesized by NRPS and PKS-I will certainly be accelerated through metagenomics, allowing the exploitation of so far untapped microbial resources in biotechnology and medicine.
非核糖体肽合成酶(NRPS)和 1 型聚酮合酶(PKS-I)是参与微生物(如细菌和真菌)产生的寡肽和聚酮类次生代谢物生物合成的多模块酶。关于 NRPS 和 PKS-I 进化基础的新发现说明了微生物如何扩展其代谢潜力。在过去的十年中,生物信息学工具的快速发展以及微生物基因组测序和注释的改进,通过基因组挖掘发现了由 NRPS 和 PKS-I 合成的新型生物活性化合物。利用这些技术发展,宏基因组学是一个快速发展的研究领域,它直接研究微生物基因组或特定的基因群及其产物。通过宏基因组学,肯定会加速发现由 NRPS 和 PKS-I 合成的新型生物活性化合物,从而利用生物技术和医学中迄今尚未开发的微生物资源。